Data / Form D filings / Telo Genomics Corp.
Telo Genomics Corp.: Form D filings
Telo Genomics Corp., a biotechnology company in Vancouver, British Columbia, Canada, filed 3 Form D notices with the SEC between 2021 and 2026. The latest, on April 24, 2026, reports $7,346 sold of a $19,100 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1060 QUEBEC STREET, Vancouver, British Columbia, Canada, V6A 4
- Phone
- (647) 477-9365
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1872138
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | New notice | $19,100 | $7,346 | $11,754 | 1 | Mar 6, 2026 | sec.gov |
| Jan 6, 2025 | New notice | $26,051 | $10,420 | $15,631 | 1 | Dec 23, 2024 | sec.gov |
| Jul 15, 2021 | New notice | $201,700 | $80,680 | $121,020 | 1 | Jun 30, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Farlinger | Executive Officer, Director | Chairman |
| Sabine Mai | Director, Promoter | |
| John Price | Executive Officer | |
| Ron McGlennen | Director |
Every Form D from the week of Apr 20, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Telo Genomics Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.